Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aishwarya Group, operating commercially as Aishwarya Healthcare, is an Indian pharmaceutical manufacturing company focused on intravenous fluids, injectables, generics, and other finished-dose medicines. The company positions itself as a global healthcare partner with exports to more than 53 countries and a portfolio spanning over 1,200 SKUs across 27 therapy areas. Its operations are built around strong in-house manufacturing, including blow-fill-seal and other sterile manufacturing capabilities, with four manufacturing facilities in Himachal Pradesh and Sikkim. In addition to hospital and prescription products, the company markets branded generics and has expanded into nephrology, ophthalmics, oncology-related oral products, and international business through AishThera. Aishwarya appears to be primarily a commercial-stage specialty and generic pharma manufacturer rather than a clinical-stage biotech innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aishwarya Group.